wwPDB validation report of PDB entry 2PDQ

NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE

{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID

Human aldose reductase complexed with uracil-type inhibitor.

ANISOTROPIC SCALING APPLIED BY THE METHOD OF PARKIN, MOEZZI & HOPE, J.APPL.CRYST.28(1995)53-56

Human aldose reductase mutant C303D complexed with uracil-type inhibitor.

The asymmetric unit contains one biological monomer.

The largest off-origin peak in the Patterson function is 7.62% of the height of the origin peak. No significant pseudotranslation is detected.

structure factor analysis and validation

geometric validation package for ligand chemistry in protein x-ray structures

20191225.v01 (using entries in the PDB archive December 25th 2019)